| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199511 | Journal of Allergy and Clinical Immunology | 2010 | 11 Pages |
Abstract
Mepolizumab is an effective corticosteroid-sparing agent for patients with L-HES. In some cases however, eosinophil levels remain above 600/μL, suggesting incomplete neutralization of overproduced IL-5 or involvement of other eosinophilopoietic factors.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Florence MD, PhD, Aurore PhD, Liliane PhD, Elie MD, PhD, Ann MS, Lori PhD, Liqiang MD, MS, Mark MD, Michel MD, PhD, Gerald J. MD, Amy MD,